share_log

ProSomnus | SC 13G: Statement of acquisition of beneficial ownership by individuals-Walleye Capital LLC(6.31%)

ProSomnus | SC 13G:超过5%持股股东披露文件-Walleye Capital LLC(6.31%)

SEC announcement ·  02/14 11:12
Moomoo AI 已提取核心信息
On December 31, 2023, Walleye Capital LLC filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.31% ownership stake in ProSomnus, Inc. This stake represents 1,103,690 shares in the company. ProSomnus, Inc. is known for its warrants, with each whole warrant exercisable for one share of common stock at $11.50 per share. The filing indicates that Walleye Capital LLC, an investment adviser based in Minnesota, holds these shares with sole voting and dispositive power. The total number of common stock shares outstanding for ProSomnus as of November 13, 2023, was 16,398,599. The Schedule 13G filing is a regulatory requirement for parties holding more than 5% of a company's stock and is not indicative of an attempt to change or influence the control of the company. The certification was signed on February 14, 2024, affirming the accuracy and completeness of the information provided.
On December 31, 2023, Walleye Capital LLC filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.31% ownership stake in ProSomnus, Inc. This stake represents 1,103,690 shares in the company. ProSomnus, Inc. is known for its warrants, with each whole warrant exercisable for one share of common stock at $11.50 per share. The filing indicates that Walleye Capital LLC, an investment adviser based in Minnesota, holds these shares with sole voting and dispositive power. The total number of common stock shares outstanding for ProSomnus as of November 13, 2023, was 16,398,599. The Schedule 13G filing is a regulatory requirement for parties holding more than 5% of a company's stock and is not indicative of an attempt to change or influence the control of the company. The certification was signed on February 14, 2024, affirming the accuracy and completeness of the information provided.
2023年12月31日,Walleye Capital LLC向美国证券交易委员会提交了附表13G,披露了Prosomnus, Inc.6.31%的所有权。该股份代表该公司1,103,690股股份。ProsomNus, Inc.以其认股权证而闻名,每份完整认股权证可行使一股普通股,价格为每股11.50美元。文件显示,总部位于明尼苏达州的投资顾问Walleye Capital LLC以唯一投票权和处置权持有这些股票。截至2023年11月13日,Prosomnus已发行的普通股总数为16,398,599股。附表13G申报是监管部门对持有公司5%以上股票的各方的要求,并不表示有人试图改变或影响公司的控制权。该认证于2024年2月14日签署,确认了所提供信息的准确性和完整性。
2023年12月31日,Walleye Capital LLC向美国证券交易委员会提交了附表13G,披露了Prosomnus, Inc.6.31%的所有权。该股份代表该公司1,103,690股股份。ProsomNus, Inc.以其认股权证而闻名,每份完整认股权证可行使一股普通股,价格为每股11.50美元。文件显示,总部位于明尼苏达州的投资顾问Walleye Capital LLC以唯一投票权和处置权持有这些股票。截至2023年11月13日,Prosomnus已发行的普通股总数为16,398,599股。附表13G申报是监管部门对持有公司5%以上股票的各方的要求,并不表示有人试图改变或影响公司的控制权。该认证于2024年2月14日签署,确认了所提供信息的准确性和完整性。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息